6 completed, 2 unknown, 1 not yet recruiting. 4 Phase 4, 2 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Unknown 1 |
| Not applicable | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow saw palmetto extract: new trials by email Literature Review of saw palmetto extract trials Research Report on saw palmetto extract
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extracorporeal Shock-Wave Therapy (ESWT) vs Phytotherapy vs Combined in Treatment of Chronic Prostatitis ESWT, Phytotherapy that contains powder extract of (saw palmetto , tomato , uva ursi , pygeum and pumpkin - Chronic Prostatitis (CP) | Not applicable | Not yet recruiting | Ain Shams University | 90 | 2025-07-20 | 2025-07-17 |
| Comparison of 2 Extracts of Saw Palmetto Versus Placebo on Lower Urinary Tract Symptoms (LUTS) and Urinary Frequency Saw palmetto extract 320mg per day, Commercial Saw palmetto extract 320mg per day, Palm Oil capsule - Lower Urinary Tract Symptoms | Phase 4 | Completed | RDC Clinical Pty Ltd | 89 | 2024-06-21 | 2025-08-20 |
| PERmixon® in LUTS Evaluation Study (PERLES) Permixon® 160 mg, Tamsulosine LP, Placebo matching Permixon® 160 mg - Benign Prostatic Hyperplasia (BPH) | Phase 4 | Completed | Pierre Fabre Medicament | 833 | 2014-04-01 | 2016-09-02 |
| Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) Permixon® 160 mg, Tamsulosine Arrow LP, Placebo matching Permixon® 160 mg - Benign Prostatic Hyperplasia (BPH) | Phase 4 | Completed | Pierre Fabre Medicament | 206 | 2012-06-01 | 2014-01-15 |
| Saw Palmetto: Symptom Management for Men During Radiation Therapy Saw Palmetto, soybean oil soft gel - Prostate Cancer | Phase 1 / Phase 2 | Completed | Michigan State University | 48 | 2011-10-01 | 2019-09-30 |
| Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions Saw palmetto berry extract - Sexual Dysfunctions in Men With Benign Prostatic Hyperplasia | Phase 4 | Unknown | A. Vogel AG | 50 | 2009-11-01 | 2009-11-26 |
| Herbal Therapy for Treatment of Recurrent Prostate Cancer Prostate Health Cocktail - Prostate Cancer | Phase 2 | Completed | University of Southern California | 43 | 2008-07-06 | 2017-04-20 |
| The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients Saw palmetto and sanmiaoshan capsule - Prostatic Hyperplasia, Adrenergic Alpha-Antagonists | Not applicable | Unknown | Hospital Authority, Hong Kong | 40 | 2006-01-01 | 2010-07-07 |
| Saw Palmetto Extract in Benign Prostatic Hyperplasia Saw Palmetto - Benign Prostatic Hyperplasia | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 224 | 1999-08-01 | 2010-01-14 |
Prostatic Hyperplasia (5) · Prostatic Neoplasms (2) · Lower Urinary Tract Symptoms (1)
Pierre Fabre Medicament (2) · A. Vogel AG (1) · Ain Shams University (1) · Hospital Authority, Hong Kong (1) · Michigan State University (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · RDC Clinical Pty Ltd (1) · University of Southern California (1)
United States (3) · France (2) · Italy (2) · Spain (2) · Australia (1) · China (1) · Czechia (1) · Egypt (1) · Germany (1) · Portugal (1) · Switzerland (1)
Amanda Rao, PhD (1) · Andrew Avins, MD, MPH (1) · Chi Fai Ng, Dr (1) · Eugen Riedi, MD (1) · Gwen Wyatt, PhD, RN (1) · Karim Keddad, MD (1) · Mohammed Y. Yassin, Professor (1) · Stephen Bent, MD (1) · Tanya Dorff, MD (1)
2014 (1), R01DK056199 (1)